The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Growth & Innovation Forum

9 Jan 2017 07:00

RNS Number : 5902T
Instem plc
09 January 2017
 

 

Instem plc

 

("Instem" or the "Company")

 

Instem plc to exhibit at Growth & Innovation Forum - Tuesday 31 January, London

 

Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, announces that the Company will be exhibiting at the Growth & Innovation Forum on Tuesday 31 January at the Business Design Centre, London.

 

Instem's management team will be at stand number 10 throughout the day and will be presenting to delegates in the Babbage Room at 10.20am. No new material information will be disclosed during the course of the day.

 

The Growth & Innovation Forum, sponsored by Cenkos and Shares magazine, is a one-day conference and exhibition which aims to showcase pioneering and imaginative technology-led firms and bring them together with the investment community. The event will run from 9.00am to 5.30pm with the conference agenda starting at 9.45am. For more information, including registration details, please visit:

 

http://www.sharesmagazine.co.uk/events/event/GIF2017

 

For further information, please contact:

 

Instem plc

+44 (0) 1785 825 600

Phil Reason, CEO

 

Nigel Goldsmith, CFO

 

 

 

N+1 Singer (Nominated Adviser & Broker)

+44 (0) 20 7496 3000

Richard Lindley

Nick Owen

James White

 

 

 

Walbrook Financial PR

+44 (0) 20 7933 8000

Paul Cornelius

instem@walbrookpr.com

Helen Cresswell

Sam Allen

 

Paul Whittington

 

 

 

About Instem plc

 

Instem is a leading supplier of IT applications and services to the early development healthcare market delivering compelling solutions for data collection, analysis and regulatory submissions management. Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.

 

Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

 

Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.

 

To learn more about Instem solutions and its mission, please visit www.instem.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAQQLFBDFFEBBL

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.